Conflict of Interest
ONCOLOGY, EMD
Pedro C. Barata has received consultant fees from Astellas, Eisai, AVEO Oncology, Janssen, EMD Serono, Dendreon, Pfizer, Seattle Genetics, BMS, Bayer, Guardant Health, Caris Life Sciences, and Myovant (unrelated to this work). Aviva Asnis-Alibozek has received medical affairs consulting fees from AVEO Oncology. Sumanta K. Pal reported travel support from Ipsen and CRISPR Therapeutics. Kimberly D. Allman and Vijay Kasturi are employees of AVEO Oncology. Alexander Chehrazi-Raffle indicated no financial relationships.